Should you go for Care Health’s new rider plan — Care Shield?

[ad_1]

Read More/Less


Care Health, earlier called Religare Health Insurance, launched a rider cover — Care Shield — in December 2020. The rider can be purchased with the company’s existing health plans Care, Care Freedom (diabetes cover) and Care Advantage (₹1- crore sum insured (SI) cover). A rider is an add-on insurance cover that comes with the basic policy for an additional price.

We review if the rider, Care Shield, is worth the money or only a cosmetic change that agents are using as a selling point.

What’s on offer

Care Shield comes with three features. One is Inflation Shield, which gives the benefit of increased SI at the time of renewal as per the Consumer Price Index (CPI) inflation rate for the previous policy year. The idea is to help policyholders afford higher medical costs.

The second feature is Claim Shield. Here, the insurer promises to cover costs of 60-plus items, such as belts, braces, buds, crepe bandages, gloves, leggings, masks, oxygen mask, spirometer, thermometer and ambulance equipment, which are used during treatment.

The third feature is No-Claim Bonus Shield where, if the policyholder has not made any claim in the previous year, the insurer will give her a reward when the policy is renewed.

This is through a bump-up in SI (by 60 per cent) at no extra cost. According to the policy brochure, this feature also ensures that any low-value claim (< 25 per cent of SI) does not lead to any erosion of the accumulated No- Claim Bonus (NCB).

For example, for a ₹10-lakh policy, if there is a claim of up to ₹2.5 lakh, there is no reduction in NCB.

Our take

Care Health’s base plan — Care — is a good product with a competitive premium. The policy allows pre- and post-hospitalisation cover of 30 days and 60 days, respectively, covers all day-care procedures, and allows claims of up to 10 per cent of SI for domiciliary hospitalisation (insured person is considered hospitalised even when she is home).

However, there is no great benefit in the Care Shield rider. First, the increase in premium offered through Inflation Shield is linked to CPI and not medical cost inflation. While CPI increases by 4-5 per cent, medical inflation is in double digits.

So, one can’t expect much relief from a CPI-linked SI increase. The insured will have to anyway increase the SI under her base plan if she wants to be covered sufficiently to ride over the inflation-linked spike in healthcare costs. It is prudent to calculate the inflation-led cost increase for at least 10 years while taking a health insurance cover and opt for a higher SI at the first instance of buying a health insurance policy.

Once you sign up for a small SI, to increase it at a later point, you will have to again undergo medical tests and it will have to be cleared by the underwriting team of the insurance company. At that stage, if you have any health complications, you may not get a higher SI.

The Claim Shield feature under Care Shield will help you save 5-7 per cent of the out-of-the-pocket expenses. However, note that most insurers today cover these costs even without a rider, unless it is a Covid-19 claim.

The last feature — No Claim Bonus Shield — is also not as great as the company claims it to be. Many insurers today allow doubling of SI if there are no claims on the policy, and also do not reduce the SI when a claim is filed irrespective of the value of the claim.

Examples here include Health Companion of Max Bupa and Lifeline of Royal Sundaram. For an SI of ₹10 lakh, a 35-year-old male will have to pay an annual premium of ₹7,004 for Care (excluding GST). If he buys Care Shield, too, the premium will increase to ₹8,265 — a 18 per cent higher outgo. This is expensive for the limited benefits the rider promises.

If you are looking for a higher NCB (doubling of SI in five no-claim years) and SI-restored benefit, you can go for Royal Sundaram’s Lifeline.

The premium is expensive but worth the features — the annual premium for a 35-year-old male for a ₹10-lakh SI comes to about ₹10,500.

Or if you want a larger cover of, say, ₹1 crore, you can consider the health policy of Max Bupa — buy it as a base policy of ₹5 lakh and a super top-up of ₹95 lakh.

[ad_2]

CLICK HERE TO APPLY

Life insurance business down 1.69% till December

[ad_1]

Read More/Less


The first-year premium of life insurers in the first three quarters of the current fiscal ended December 31, 2020, declined 1.69 per cent at ₹1,91,046 crore as against ₹1,94, 331 crore in the corresponding period of the previous fiscal.

The first year premium of Life Insurance Corporation of India (LIC) decreased 5.13 per cent at ₹1,30, 004 crore as against ₹1,37,034 crore in the same period last year, according to business figures released by the Insurance Regulatory and Development Authority of India.

For the state insurer, there was a dip in individual and group non-single premium and group yearly renewable premium while individual single and group premiums went up.

For private insurers, however, the first year premium went up by 6.54 per cent at ₹61,042 crore compared with ₹57,269 crore in the previous year.

There was growth in all segments except individual non-single premium for private insurers.

[ad_2]

CLICK HERE TO APPLY

Readers’ feedback – The Hindu BusinessLine

[ad_1]

Read More/Less


The articles covered by your esteemed newspaper are very informative and well-researched. May I request you to extend your coverage to issues related to autumn years, especially on health insurance plans and pension-related matters?

—Subrata Saha

BL Research Bureau(BLRB) says: Thanks for writing to us. We do write on investment, insurance and pension options for senior citizens from time to time. Keep reading!

I am an avid reader of BusinessLine, especially the Portfolio edition on Sundays. It is a compass for investors to navigate the ocean of finance. My suggestions for further enhancement:

– Include MFs investing in global equity stocks in Star Track MF Ratings. Further introduce index funds and ETFs which are very helpful to most investors.

– Provide a separate section for growth and value stocks identified by your research team and discuss those stocks in-depth at least 3-5 in number every week.

—Sankara Madhava Prasad, Hyderabad

BLRB says: Thank you for your valuable feedback and suggestions. We will strive to incorporate them.

Your analysis of topics is very vast and is inclusive of even minute details. Readers are totally engrossed. Star Track MF Ratings is like a holy grail for new investors, especially since knowledge and exposure regarding returns is limited for a majority of common people. Your reporting of the stock market is very good and extensive. It would be nice to have additional information on international stocks and modes of investment in global markets for small-time investors. Keep up the good work. I’m not an expert, but I really appreciate the efforts the reporters have put in to research their respective articles.

––Dr Nisha Prakash

BLRB says: Thank you for your feedback. With the launch of the refreshed Portfolio edition, we have started covering international stocks. In fact, today’s edition has an international stock recommendation.

We have written on modes of investing in global markets in our edition dated September 13, 2020. We will keep writing more on international investing. Keep reading!

This is with respect to the Big Story published on December 3, 2020. Thanks for a great summing up of the investment ideas for 2021.

The story covers where the opportunities lie, explaining the economic recovery angle, the reasons for and the types of bull market, and the types of and the areas where growth is likely.

While suggesting to take a middle path and de-risking, I wish the writer could have given her valued suggestions, for those who en-cashed at the news a of second wave and new lockdown in Europe, before indices shot up again.

The nice suggestions by Maulik Madhu on the fixed income side is also very informative and useful. I am a fan of Aarati Krishnan’s regular presentations in BL and her the webinars on investor education.

––PS Ramachandran, Chennai

I have been reading BusinessLine for the past 12 years.

Thanks for restarting BL Sunday Portfolio, though it may be extra work on weekend for the BL staff.

It is a fantastic, very comprehensive read on equity, mutual funds, market analysis, etc, plus other asset classes such as debt and gold.

The Sunday edition is very useful as it gives readers time to read through in a relaxed way. I would just add that since I have been a reader for 12 years, the weekday edition is more thin and the quality has dropped compared with others. But great Sunday edition and thank you for increasing investor education among the readers.

––Krishnan CA, Bengaluru

BL says: Thank you for the comments on the Sunday edition. The weekday edition will grow in size and quality as the economy stabilises going forward.

You must have noticed the special pages we now offer on Mondays, covering an entire gamut of topics, ranging from science and technology to advertising, and business laws to a deep-dive section on corporate developments.

[ad_2]

CLICK HERE TO APPLY

23 MidCap Stock Ideas For Short-Term Gains In 2021

[ad_1]

Read More/Less


ICICI Securities’ picks

ICICI Securities believe that broader market would relatively outperform the benchmark in the medium term and picked five mid-cap stocks after rigorous research that could provide “handsome” returns.

“Within mid-cap space we have spotted consumer discretionary sector based on its higher relative strength ranking, where we can capture higher beta. We have run rigorous filters to identify such stocks that have the ability to withstand storm and relatively outperform the benchmark as these stocks have approached their key supports and thereby offers favourable risk-reward,” the brokerage said.

ICICI Securities’ picks: Voltas, Crompton Greaves, Vguard, Symphony and Bajaj Electricals.

Axis Securities' midcap picks

Axis Securities’ midcap picks

Axis Securities noted that after a prolonged period of weakness, the small and mid-cap stocks have outperformed the large-cap indices by a significant margin.

“The year 2021 will be a year of economic revival with GDP growth rate closer to double digits. Notwithstanding the low base, the economic revival will usher stronger earnings growth. In a year of strong earnings growth, mid and small caps tend to see market-beating earnings growth and rerating. Small and mid-cap stocks are likely to deliver very strong returns and when combined with other dominant themes then returns will be even stronger,” the brokerage said.

Its preferred themes for the year include Digital, Healthcare and Telecom. The brokerage believes that while all these themes were promising even before COVID-19, the pandemic has resulted in business transformation decisions which were unthinkable a year ago.

Axis Securities’s midcap picks:

1. Relaxo Footwear

With a target price of Rs 925, the brokerage explained it picked the stock because of:

  • Mass and value proposition the core
  • Healthy return ratios and balance sheet
  • Further Capex to drive growth

2. Amber Enterprises

With a target price of Rs 2,800, the brokerage explained it picked the stock because of the following factors:

  • Most backward integrated player in India and strategic plant locations
  • Strong traction in RAC demand
  • Increased localisation to aid business
  • Commercial AC segment foray
  • Planned capex to augur well with PLI on the cards

3. Star Cement

With a target price of Rs 115, the brokerage explained it picked the stock because of the following factors:

  • Capacity expansion to drive volume and revenue growth for the company
  • Strong market presence in its key market of North East & growing in East India
  • Integrated nature of operation with efficient cement plants
  • Healthy Financials to support future growth

HDFC Securities' Picks

HDFC Securities’ Picks

HDFC Securities Retail Research has filtered a handful of stock ideas for the next two quarters which the brokerage believes may earn between 20% and 29% from their current market price in up to six months.

1. Spandana Sphoorty Financial

Target Price: Rs 928

The third-largest NBFC-MFI in India with AUM (Assets Under Management) of Rs 7,354 crore, has strengthened its risk management process after every crisis and diversified geographically to reduce the impact thereof, said the brokerage.

Post the easing of lockdown all its branches became operational by May-end. It has provided for ~6% of its portfolio and with improving collection trends (Oct-20 absolute collections at 110%) might not be required to make significant provisions going forward, HDFC Securities said. NPA levels are comfortable and capital raising in the last few years has led to a strong capital adequacy ratio of 45%, it added.

2. Dollar Industries

Target Price: Rs 273

HDFC Securities Retail Research believes that post the introduction of GST and the COVID-19 outbreak, low-ticket sized branded knitted-wear as a category is all set to go through a structural shift. The brokerage expects the company to record a Revenue and PAT CAGR of 6% and 20% over FY20-23E. Higher PAT growth is likely to be mainly driven by cost rationalization measures and debt reduction.

3. Healthcare Global Enterprises

Target Price: Rs 198

Having doubled bed capacity over the last five years, the brokerage expects HCG’s capex phase to ease from FY21. “Large part of bed expansion is done and we expect incremental losses to be offset by earlier hospitals turning positive,” says HDFC Securities.

In the past 36 months, HCG launched 7 new cancer care facilities across the country, reaching out to more cancer patients across metros as well as Tier-I & Tier-II cities.

4. DCB Bank

Target Price: Rs 144

DCB Bank has managed to maintain healthy capitalisation, sustainable and calibrated growth in advances with continued focus on the SME segment, competitive NIMs, comfortable asset quality with stable management team, HDFC Securities said. The company has strong capital adequacy, a comfortable liquidity position, a resilient operating model and increasing retail mix.

The retail focus will help the Bank to deliver double-digit growth in loan book from next fiscal, the brokerage said.

5. Coal India

Target Price: Rs 165

“The focus on renewable and other clean forms of energy sources remains a concern for the longer term, however we believe that those concerns are already factored in the current prices. Coal India has taken major initiatives to build matching logistics infrastructure to ensure evacuation of planned quantity of production,” says HDFC Securities.

The stock has significantly underperformed the benchmark indices over the last few years on the back of multiple factors acting against the company. The brokerage believes most of the negatives are priced in and the extent of de-rating in the stock is not justified given its fundamentals.

“We however do not have a very positive view on the stock for the long term but feel that there is tactical opportunity for the short term in the stock,” says HDFC Securities.

6. Birla Corporation

Target Price: Rs 874

The industry has a high dependence on real estate and infra sector which is expected to be impacted due to expected slowdown in the economy, says the brokerage.

Going forward, HDFC Sec expects a gradual recovery in cement demand and volumes are likely to pick-up from the second-half of FY21. In the case of Birla Corp, incremental volumes from the commencement of additional capacities will result in a lower decline in volumes compared to the industry. Also, on the demand side, key growth drivers are likely to be picked up in rural housing, Pradhan Mantri Awas Yojana (rural), Pradhan Mantri Gram Sadak Yojana and spending on key infrastructure projects.

Jefferies' picks

Jefferies’ picks

Jefferies India feels that the underperformance of the midcap segment has reversed. It believes that the continued easy global liquidity and expected cyclical recovery in India should be a supportive environment for mid-caps.

The brokerage’s analysis of past performance suggests that mid-caps have tended to outperform large caps when growth accelerates in India or is trending high.

“With GDP growth rising to 13% in FY22, and broad-basing happens in economic activity thanks to a cyclical pick-up in property, mid-caps should do well,” it said.

“2021 is likely to mark the turn in the property cycle which is likely to benefit companies across the value chain,” the report said.

Jefferies India likes Oberoi Realty, Kajaria Ceramics and Supreme Industries.

Its other mid-cap picks include Varun Beverages, Graphite India, Dixon Technologies, MGL, IGL and Container Corporation of India.



[ad_2]

CLICK HERE TO APPLY

Reserve Bank of India – Tenders

[ad_1]

Read More/Less


E-tender- No: RBI/Kochi/Estate/298/20-21/ET/414

Reserve Bank of India, Kochi invites two-part tender by e-tender mode for Renovation of two Class III type flats and staircase area at Bank’s Staff Quarters, Kaloor, Kochi. The tendering would be done through the E-Tendering mode from empanelled contractors.

The Schedule of e-Tender is as follows:

a. E-Tender No. RBI/Kochi/Estate/298/20-21/ET/414
b. Name of work: Renovation of two Class III type flats and staircase area at Bank’s Staff Quarters, Kaloor, Kochi
c. Mode of Tender e-Procurement System Online (Part I – Techno-Commercial Bid and Part II – Financial Bid through MSTC portal (https://www.mstcecommerce.com/eprochome/rbi)
d. Date of NIT available to the parties to download / View Tender Time 10:00 Hrs of January 09, 2021 onwards
e. Estimated cost of work (for an year) ₹ 8,90,000/- (Rupees Eight lakh Ninety thousand only) inclusive of GST
f. Earnest Money Deposit (EMD) Shall be collected from successful bidder @2% of the Contract value of work, on awarding the work.
g. Bidding start date of Techno-Commercial Bid and Financial Bid at https://mstcecommerce.com/eprochome/rbi 10:00 Hrs. of January 09, 2021
h. Date of closing of online e-Tender for submission of Techno-Commercial Bid & Financial Bid 10:00 Hrs. of January 25, 2021
i. Date & time of opening of
Part-I (i.e. Techno-Commercial Bid)
11:00 Hrs. of January 25, 2021
j. Date & Time of opening of Part- II (Financial Bid) On same day above or subsequent day which will be intimated to all the bidders later
k. Transaction Fee Amount as advised by M/s MSTC Ltd.

(Vijay Kumar Nayak)
General Manager (O-i-C)
Reserve Bank of India
Kochi
January 09, 2021

[ad_2]

CLICK HERE TO APPLY

Deutsche Bank to pay $100 million to avoid bribery charge, BFSI News, ET BFSI

[ad_1]

Read More/Less


Deutsche Bank has agreed to pay a fine of more than $100 million to avoid a criminal prosecution on charges it participated in a foreign bribery scheme. Lawyers for the bank waived its right to face an indictment on conspiracy charges Friday during a teleconference with a federal judge in New York City.

Federal prosecutors in Brooklyn didn’t reveal at the hearing which nations were involved. Previously, the bank has agreed to a Securities and Exchange Commission fine of $16 million to resolve separate allegations of corrupt dealings in Russia and China.

Deutsche Bank said it would have no immediate comment. The bank’s agreement to avoid prosecution comes in the waning days of the administration of President Donald Trump, who had a longtime personal business association with the bank.

Follow and connect with us on , Facebook, Linkedin



[ad_2]

CLICK HERE TO APPLY

Bose, pioneer of investment banking in India, dies at 71, BFSI News, ET BFSI

[ad_1]

Read More/Less


Veteran dealmaker Udayan Bose, who brought modern investment banking and venture capital to India in the ’80s and set up the second private Indian mutual fund, passed away on Friday. Bose (71) was suffering from heart and kidney-related issues.

Bose straddled the world of pinstriped bankers of London’s Lombard Street and the earthy stock markets of Mumbai and Kolkata. He threw away an opportunity to head Deutsche Bank’s Australia operations to turn entrepreneur by acquiring a vintage broking firm, which then he used to partner Lazard (a global investment bank) and create India’s first multinational investment bank.

A young achiever from Kolkata’s Presidency College, Bose started his career with Grindlays Bank where he rose to be a director of Asia-Pacific before moving on to European Asian Bank (which became Deutsche Bank). As a merchant banker (as investment bankers were known then), he helped movers and shakers of the ’80s and ’90s strike deals, like R P Goenka’s acquisition of HMV.

Uday Kotak, who has been part of the city’s capital market scene from the ’80s, says he has great memories of Bose. “I met him in the European Asian Bank, which later became Deutsche Bank. After Deutsche, he bought over a broking firm — Merwanji Bomanji and Dalal — and partnered with Lazard. An original merchant banker, and a professional-turnedentrepreneur… Time flies. Will miss him,” said Kotak.

Ravi Rangachari, former director (finance & corporate affairs) at Lazard India, said, “Bose was ahead of his time… he had great vision.” Another one of Bose’s Indian ventures was the British Tech Group, which pioneered the concept of licensing and adoption of foreign technologies for Indian companies.

In 1984, after he was appointed head of Deutsche Bank’s operations in Australia, he was swept by a “feeling of belonging to the soil” and gave up the prestigious assignment and decided to start investment bank Credit Capital in India. His connections and knowledge brought him several board positions, prominent among them being the chairmanship of travel firm Thomas Cook.

Other companies where he was on the board included HMV, Reliance Capital, and JK Paper. A big believer in the India story, Bose took over as chairman of the Kolkata Stock Exchange in the hope of modernising it and bringing foreign investors.

An anglicised banker with a baritone, Bose would at times appear incongruous among desi stockbrokers, whether in Mumbai or Kolkata. But deep inside, he still had middle-class family values. Once when talking to a reporter on a major assignment that he was taking, he requested that his picture be carried in the Kolkata edition as that would make his mother happy. An epicure, he enjoyed cooking for, and feeding, people. And he loved a good adda.



[ad_2]

CLICK HERE TO APPLY

China fines 7 financial institutions $31 million over irregularities, BFSI News, ET BFSI

[ad_1]

Read More/Less


Leading policy bank China Development Bank, top lenders China Industrial and Commercial Bank of China , and the fifth largest state lender Postal Savings Bank of China are among those fined, according to a statement from the China Banking and Insurance Regulatory Commission.



[ad_2]

CLICK HERE TO APPLY

HDFC Bank | Aditya Puri: Former HDFC Bank MD Aditya Puri joins global pharma major Strides Group as advisor, BFSI News, ET BFSI

[ad_1]

Read More/Less


Former HDFC Bank managing director Aditya Puri has joined global pharma major Strides Group as an advisor and will also serve as a director of its associate company Stelis Biopharma. “Eminent corporate doyen Aditya Puri joins the Strides Group as an advisor and also will be a director of its associate company, Stelis Biopharma,” Strides Pharma Science said in a regulatory filing.

Strides Pharma Science said Puri’s appointment to the Stelis board comes at an exciting juncture for the company as it transitions from its incubation phase to a consolidation and growth phase to establish itself as a partner of choice globally with the aim of bringing world-class treatments at affordable costs to patients in both emerging and developed markets.

On his appointment, Puri said the Stride Group’s established parentage, global success and headstart in terms of basic infrastructure gives him the opportunity to be involved in and guide Stelis and other Group endeavours in their exciting growth story.

Arun Kumar, Founder and Chairman of the Board of Strides, said: “I am delighted to welcome Aditya as our advisor and to the Stelis board. This a huge vote of confidence in the potential of Stelis. Aditya’s illustrious legacy is well-known. Having nurtured HDFC Bank since inception, his deep experience will be extremely valuable for the Strides Group and Stelis in particular.

“With Stelis poised for its next leg of growth, this is the right time to expand the board, and ensure robust guidance and governance by the best possible industry minds. I look forward to working with Aditya and leveraging his expertise to take Stelis to new heights”.

Puri, who led HDFC Bank since its inception over 25 years ago, retired in October 2020, after a highly successful career which has made the bank the largest among private sector lenders.

While heading a foreign bank’s operations in Malaysia in the early 1990s, Puri got an offer from Deepak Parekh of mortgage major HDFC to come back to India to start a bank in an economy which had shifted gears with liberalisation moves.

In November 2020, Puri was roped in by US-based global investment firm Carlyle Group as a senior advisor.



[ad_2]

CLICK HERE TO APPLY

DHFL FD holders plan to vote against resolution on distribution mechanism

[ad_1]

Read More/Less


Deposit holders have admitted claims of over Rs 5,500 crore from DHFL.

By Ankur Mishra

Several fixed deposit (FD) holders of Dewan Housing Finance Corporation (DHFL) are planning to vote against the resolution on the ‘distribution mechanism’ from the prospective recovery amount for the lender. Vinay Kumar Mittal, a lead petitioner in the court on behalf of FD holders, told FE that depositors are going to vote against the resolution as many of them will recover a negligible amount as per proposal. Deposit holders have admitted claims of over Rs 5,500 crore from DHFL.

The resolution on distribution mechanism is open for voting till January 15 and it proposes to categorise FD holders and non-convertible debenture (NCD) holders into four brackets based on their admitted claims. The first bracket will be up to Rs 2 lakh, the second category is between Rs 2 lakh to Rs 5 lakh. The third category is between Rs 5 lakh to Rs 10 lakh and the fourth one is over and above admitted claims of Rs 10 lakh. The resolution proposes to pay full principal amount to first category of FD and NCD holders under Rs 2 lakh bracket.

The resolution says, “The aggregate additional amounts to be distributed to the FD holders in category 1 and secured NCD holders in category 1 shall be paid in full to the extent of principal from upfront cash up to 2% of the resolution plan payment with the intention of providing the maximum principal recovery to the basis amounts available.”

Vinay Kumar Mittal said FD holders, barring those in Rs 2 lakh bracket, are going to lose maximum amount of money as their recovery is not defined in the plan. “Even if, committee of creditors (CoC) approves the resolution due to their large voting share, we will fight the matter in court,” he said. The National Company Law Tribunal is separately hearing FD holders’ petition on DHFL dues. The court is slated to hear the matter next on January 20,2021. “We had invested our hard-earned savings into a AAA rated company regulated by National Housing Bank (NHB) and Reserve Bank of India (RBI), then why should we lose whole amount?” he said.

Along with the resolution on distribution mechanism, the lenders have started voting on the bids submitted by Oaktree Capital, Piramal Capital and Housing Finance (PCHFL) and Adani Properties for DHFL. The troubled lender has admitted claims of Rs 87,407 crore, with State Bank of India being the lead creditor. DHFL is undergoing insolvency proceedings at NCLT, Mumbai since December 3, 2019.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.



[ad_2]

CLICK HERE TO APPLY

1 63 64 65 66 67 87